论文部分内容阅读
目的:探讨分析乌司他丁联合奥曲肽治疗重症急性胰腺炎的临床效果。方法:选取重症急性胰腺炎的患者60例为本次研究对象。通过盲选平均分方法将60例重症急性胰腺炎患者均分三组,命名为对照A组,对照B组,研究组。三组患者均接受常规治疗,在此基础上,给予对照A组使用乌司他丁治疗,给予对照B组使用奥曲肽治疗,给予研究组使用乌司他丁联合奥曲肽治疗,三组持续治疗7日,并将三组患者的临床治疗效果进行比较分析。结果:(1)三组患者的临床治疗效果比较,研究组明显优于对照A组,对照B组,P<0.05。结论:乌司他丁联合奥曲肽治疗重症急性胰腺炎的临床效果显著,值得临床做进一步的推广及应用。
Objective: To investigate the clinical effect of ulinastatin combined with octreotide in the treatment of severe acute pancreatitis. Methods: 60 patients with severe acute pancreatitis were selected as the study subjects. Sixty patients with severe acute pancreatitis were equally divided into three groups by blind selection and average score method, named as control group A, control group B and study group. Three groups of patients received routine treatment, on this basis, the control group A was given ulinastatin, the control group B was treated with octreotide, the study group was treated with ulinastatin and octreotide, and the three groups were treated for 7 days , And the clinical treatment of three groups of patients for comparative analysis. Results: (1) Compared with the clinical efficacy of the three groups, the study group was significantly better than the control group A, control group B, P <0.05. Conclusion: The clinical effect of ulinastatin combined with octreotide in treatment of severe acute pancreatitis is significant and worthy of further promotion and application in clinic.